3-D Matrix Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3410730000
JPY
464.00
1 (0.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.28 M

Shareholding (Oct 2025)

FII

0.02%

Held by 1 FIIs

DII

99.98%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

With a growth in Net Sales of 16.85%, the company declared Outstanding results in Apr 25

  • The company has declared positive results for the last 5 consecutive quarters
  • NET SALES(HY) At JPY 3,659.7 MM has Grown at 32.96%
  • INVENTORY TURNOVER RATIO(HY) Highest at 0.94%
  • DEBT-EQUITY RATIO (HY) Lowest at 61.39 %
2

With ROE of -37.31%, it has a risky valuation with a 5.96 Price to Book Value

3

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 57,702 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

0.76%

stock-summary
Price to Book

14.59

Revenue and Profits:
Net Sales:
1,875 Million
(Quarterly Results - Apr 2025)
Net Profit:
-1,107 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
41.03%
0%
41.03%
6 Months
94.96%
0%
94.96%
1 Year
251.52%
0%
251.52%
2 Years
321.82%
0%
321.82%
3 Years
48.24%
0%
48.24%
4 Years
7.66%
0%
7.66%
5 Years
49.68%
0%
49.68%

3-D Matrix Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
59.69%
EBIT Growth (5y)
9.33%
EBIT to Interest (avg)
-242.52
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
1.06
Tax Ratio
0.89%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.96
EV to EBIT
-15.36
EV to EBITDA
-15.36
EV to Capital Employed
4.40
EV to Sales
2.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.64%
ROE (Latest)
-37.31%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Oct 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Apr 2025 is 16.85% vs 112.33% in Apr 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Apr 2025 is -349.19% vs 222.32% in Apr 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Apr'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,874.70",
          "val2": "1,604.40",
          "chgp": "16.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-550.20",
          "val2": "-498.70",
          "chgp": "-10.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.80",
          "val2": "21.00",
          "chgp": "-29.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.50",
          "val2": "44.80",
          "chgp": "-85.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,107.40",
          "val2": "444.40",
          "chgp": "-349.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-293.50%",
          "val2": "-310.90%",
          "chgp": "1.74%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Apr'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Apr 2025 is 51.11% vs 98.30% in Apr 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Apr 2025 is -878.94% vs 89.55% in Apr 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Apr'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,934.10",
          "val2": "4,588.80",
          "chgp": "51.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1,156.20",
          "val2": "-2,117.00",
          "chgp": "45.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "74.40",
          "val2": "83.80",
          "chgp": "-11.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.60",
          "val2": "-164.80",
          "chgp": "102.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,501.20",
          "val2": "-255.50",
          "chgp": "-878.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-166.70%",
          "val2": "-461.30%",
          "chgp": "29.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'25 - YoYstock-summary

Apr'25
Apr'24
Change(%)
Net Sales
1,874.70
1,604.40
16.85%
Operating Profit (PBDIT) excl Other Income
-550.20
-498.70
-10.33%
Interest
14.80
21.00
-29.52%
Exceptional Items
6.50
44.80
-85.49%
Consolidate Net Profit
-1,107.40
444.40
-349.19%
Operating Profit Margin (Excl OI)
-293.50%
-310.90%
1.74%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Apr 2025 is 16.85% vs 112.33% in Apr 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Apr 2025 is -349.19% vs 222.32% in Apr 2024

Annual Results Snapshot (Consolidated) - Apr'25stock-summary

Apr'25
Apr'24
Change(%)
Net Sales
6,934.10
4,588.80
51.11%
Operating Profit (PBDIT) excl Other Income
-1,156.20
-2,117.00
45.38%
Interest
74.40
83.80
-11.22%
Exceptional Items
4.60
-164.80
102.79%
Consolidate Net Profit
-2,501.20
-255.50
-878.94%
Operating Profit Margin (Excl OI)
-166.70%
-461.30%
29.46%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Apr 2025 is 51.11% vs 98.30% in Apr 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Apr 2025 is -878.94% vs 89.55% in Apr 2024

stock-summaryCompany CV
About 3-D Matrix Ltd. stock-summary
stock-summary
3-D Matrix Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available